129 related articles for article (PubMed ID: 21839774)
21. Suboptimal performance of APRI and FIB-4 in ruling out significant fibrosis and confirming cirrhosis in HIV/HCV co-infected and HCV mono-infected patients.
Mazzola G; Adamoli L; Calvaruso V; Macaluso FS; Colletti P; Mazzola S; Cervo A; Trizzino M; Di Lorenzo F; Iaria C; Prestileo T; Orlando A; Di Marco V; Cascio A
Infection; 2019 Jun; 47(3):409-415. PubMed ID: 30519966
[TBL] [Abstract][Full Text] [Related]
22. The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection.
Vergara S; Macías J; Rivero A; Gutiérrez-Valencia A; González-Serrano M; Merino D; Ríos MJ; García-García JA; Camacho A; López-Cortés L; Ruiz J; de la Torre J; Viciana P; Pineda JA;
Clin Infect Dis; 2007 Oct; 45(8):969-74. PubMed ID: 17879910
[TBL] [Abstract][Full Text] [Related]
23. Coinfection by human immunodeficiency virus and hepatitis C virus: noninvasive assessment and staging of fibrosis.
Resino S; Sánchez-Conde M; Berenguer J
Curr Opin Infect Dis; 2012 Oct; 25(5):564-9. PubMed ID: 22744318
[TBL] [Abstract][Full Text] [Related]
24. Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes.
Macías J; Girón-González JA; González-Serrano M; Merino D; Cano P; Mira JA; Arizcorreta-Yarza A; Ruíz-Morales J; Lomas-Cabeza JM; García-García JA; Corzo JE; Pineda JA
Gut; 2006 Mar; 55(3):409-14. PubMed ID: 16118349
[TBL] [Abstract][Full Text] [Related]
25. Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers.
Sánchez-Conde M; Montes-Ramírez ML; Miralles P; Alvarez JM; Bellón JM; Ramírez M; Arribas JR; Gutiérrez I; López JC; Cosín J; Alvarez E; González J; Berenguer J
J Viral Hepat; 2010 Apr; 17(4):280-6. PubMed ID: 19732322
[TBL] [Abstract][Full Text] [Related]
26. Non-invasive fibrosis biomarkers - APRI and Forns - are associated with liver stiffness in HIV-monoinfected patients receiving antiretroviral drugs.
Hasson H; Merli M; Galli L; Gallotta G; Carbone A; Messina E; Bagaglio S; Morsica G; Salpietro S; Castagna A; Lazzarin A; Uberti-Foppa C
Liver Int; 2013 Aug; 33(7):1113-20. PubMed ID: 23534616
[TBL] [Abstract][Full Text] [Related]
27. Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with post-antiviral treatment results.
Başar O; Yimaz B; Ekiz F; Giniş Z; Altinbaş A; Aktaş B; Tuna Y; Çoban S; Delibaş N; Yüksel O
Clin Res Hepatol Gastroenterol; 2013 Apr; 37(2):152-8. PubMed ID: 23391746
[TBL] [Abstract][Full Text] [Related]
28. [Grade of consistency existing in the grade of hepatic fibrosis calculated with the APRI and FORNS biochemistry indexes and transient elastography (Fibroscan in patients coinfected with HIV-HCV].
Ibáñez JG; Pérez M; Lamas JL; Ocampo A; Vázquez CM; Ribera A
Rev Clin Esp; 2010; 210(7):317-22. PubMed ID: 20466359
[TBL] [Abstract][Full Text] [Related]
29. Estimated liver fibrosis and its impact on all-cause mortality of HCV-monoinfected and HCV/HIV-coinfected drug users.
Sanvisens A; Fuster D; Serra I; Tor J; Tural C; Rey-Joly C; Muga R
Curr HIV Res; 2011 Jun; 9(4):256-62. PubMed ID: 21675942
[TBL] [Abstract][Full Text] [Related]
30. High plasma CXCL10 levels are associated with HCV-genotype 1, and higher insulin resistance, fibrosis, and HIV viral load in HIV/HCV coinfected patients.
Berenguer J; Fernandez-Rodríguez A; Jimenez-Sousa MA; Cosín J; Zarate P; Micheloud D; López JC; Miralles P; Catalán P; Resino S
Cytokine; 2012 Jan; 57(1):25-9. PubMed ID: 22136974
[TBL] [Abstract][Full Text] [Related]
31. Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers.
Islam S; Antonsson L; Westin J; Lagging M
Scand J Gastroenterol; 2005 Jul; 40(7):867-72. PubMed ID: 16109665
[TBL] [Abstract][Full Text] [Related]
32. HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease.
Nunes D; Fleming C; Offner G; O'Brien M; Tumilty S; Fix O; Heeren T; Koziel M; Graham C; Craven DE; Stuver S; Horsburgh CR
J Acquir Immune Defic Syndr; 2005 Dec; 40(5):538-44. PubMed ID: 16284529
[TBL] [Abstract][Full Text] [Related]
33. Combined use of aspartate aminotransferase, platelet count and matrix metalloproteinase 2 measurements to predict liver fibrosis in HIV/hepatitis C virus-coinfected patients.
Macías J; Mira J; Gilabert I; Neukam K; Roldán C; Viloria M; Moro A; Pineda JA
HIV Med; 2011 Jan; 12(1):14-21. PubMed ID: 20497249
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus.
Berenguer J; Zamora FX; Aldámiz-Echevarría T; Von Wichmann MA; Crespo M; López-Aldeguer J; Carrero A; Montes M; Quereda C; Téllez MJ; Galindo MJ; Sanz J; Santos I; Guardiola JM; Barros C; Ortega E; Pulido F; Rubio R; Mallolas J; Tural C; Jusdado JJ; Pérez G; Díez C; Álvarez-Pellicer J; Esteban H; Bellón JM; González-García J;
Clin Infect Dis; 2015 Mar; 60(6):950-8. PubMed ID: 25422386
[TBL] [Abstract][Full Text] [Related]
35. Assessment of allograft fibrosis by transient elastography and noninvasive biomarker scoring systems in liver transplant patients.
Beckebaum S; Iacob S; Klein CG; Dechêne A; Varghese J; Baba HA; Sotiropoulos GC; Paul A; Gerken G; Cicinnati VR
Transplantation; 2010 Apr; 89(8):983-93. PubMed ID: 20335832
[TBL] [Abstract][Full Text] [Related]
36. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
[TBL] [Abstract][Full Text] [Related]
37. Validation of three non-invasive markers in assessing the severity of liver fibrosis in chronic hepatitis C.
Shaikh S; Memon MS; Ghani H; Baloch GH; Jaffery M; Shaikh K
J Coll Physicians Surg Pak; 2009 Aug; 19(8):478-82. PubMed ID: 19651008
[TBL] [Abstract][Full Text] [Related]
38. Noninvasive scoring algorithm to identify significant liver fibrosis among treatment-naive chronic hepatitis C patients.
Koller T; Kollerova J; Huorka M; Meciarova I; Payer J
Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1108-15. PubMed ID: 25188444
[TBL] [Abstract][Full Text] [Related]
39. Evaluating liver fibrosis progression and the impact of antiretroviral therapy in HIV and hepatitis C coinfection using a noninvasive marker.
Al-Mohri H; Murphy T; Lu Y; Lalonde RG; Klein MB
J Acquir Immune Defic Syndr; 2007 Apr; 44(4):463-9. PubMed ID: 17211282
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic accuracy of transient elastography (FibroScan) versus the aspartate transaminase to platelet ratio index in assessing liver fibrosis in chronic hepatitis B: the role in primary care setting.
Lesmana CR; Salim S; Hasan I; Sulaiman AS; Gani RA; Pakasi LS; Lesmana LA; Krisnuhoni E; Budihusodo U
J Clin Pathol; 2011 Oct; 64(10):916-20. PubMed ID: 21670074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
